Articles On Telix Pharmaceuticals (ASX:TLX)

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in morning trade. At the time of writing the clinical-stage biopharmaceutical company’s shares are up almost 2.5% to $1.54. Today’s gain means that Telix’s shares are n...

I wanted to take this opportunity, on behalf of the whole team here at The Motley Fool, to wish all of our members and readers a very Merry Christmas. There are plenty of other places to go for investment advice. We’re humbled that you’ve...

ASX pharma group Telix Pharmaceuticals Ltd (ASX: TLX) is one company worth watching this morning. The Telix share price could climb higher after receiving a research grant from Cancer Australia yesterday. What did Telix announce yesterday?...

20 Dec 2019 - Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that Telix collaborator Professor Frédéric Hollande has been awarded a research gran…

Pharmaxis (ASX:PXS) has some big news from its German partner, but won’t yet say whether it’s good or bad. The company has been waiting on pharmaceutical major Boehringer Ingelheim to decide whether it wants to go ahead and further develop...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

Drug Development Process The drug development process starts from drug discovery and ends at the launch of the new pharmaceutical product in the market. The process includes drug discovery and development, preclinical trials, clinical trial...

One of the oldest tropes in journalism is the miracle cure. Startup Daily is old enough to remember when Filipino faith healers were all the rage in the 1980s – think Penn & Teller meets House. More recently, there was US blood-testing...

There are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so — but less than 25 are anywhere close to their ultimate dream of bringing a drug successfully to market, a Stockhead analysis has found. Ta...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has dropped lower with the market on Wednesday. In afternoon trade the pharmaceutical company’s shares are down 1% to $1.61 despite the release of a positive announcement. What did Telix...

See our brand new top 10 broker reviews. Find your perfect platform! Tom Bleakley, BW Equities BUY RECOMMENDATIONS Telix Pharmaceuticals (TLX) Chart: Share price over the year TLX is a clinical stage biopharmaceutical company, focusing on d...

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of In…

Telix Pharmaceuticals Limited (ASX: TLX) has entered into conditional purchase agreement with Eckert & Ziegler Strahlen und Medizintechnik Aktiengesellschaft to acquire a licensed radiopharmaceutical production facility in Seneffe, Belg...

The Telix Pharmaceuticals Ltd  (ASX: TLX) share price is one to watch in early trade after the company announced a new market acquisition this morning. What did Telix Pharmaceuticals announce? Telix announced that it has entered into a con...

03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production f…

Health care industry Australian health care industry is not just on a strong growth path but also competes on the global scale. Health Care comprises of a dynamic sector including pharmaceuticals, medical devices, health insurance and hospi...

Imagion Biosystems: Breakthrough Device By Pitt Street Research An innovative medical device company   Imagion Biosystems ((IBX)) is an Australian medical device company whose MagSense diagnostic imaging technology, currently in early stage...

ASX code: IBX Market cap: $12.95m Share price: 4c Shares on issue: 323,705,324 Chairman and CEO: Bob Proulx Board*: Bob Proulx, Michael Harsh, Jovanka Naumoska, Bronwyn Le Grice, Mark Van Asten, David Ludvigson *Dr John Hazle resigned in la...

One area of the share market which I think has strong long term growth potential is the healthcare sector. This is due to ageing populations, increased chronic disease burden, population growth, and technological advances to name just four...

On Friday the Mayne Pharma Group Ltd (ASX: MYX) share price has dropped to within a whisker of a multi-year low following the release of its full year results. At the time of writing the pharmaceutical company’s shares are down 2% to 46.5...

Telix Pharmaceuticals (ASX:TLX) has announced subscriptions under its Share Purchase Plan (SPP) totalled approximately $9.6 million.

The PolyNovo Ltd (ASX: PNV) share price was amongst the best performers on the All Ordinaries index on Thursday. The medical device company’s shares were up over 10% at one stage before ending the day 9% higher at $1.60. Why did the PolyNo...

Biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has been given the green light to commence a phase two study involving its medical imaging technology on prostate cancer patients. The company today announced it has received regula...

Shares in Immuron took a 17 per cent hit this morning after the company revealed its IMM-124E drug did not work in a trial with patients suffering from severe alcoholic hepatitis. Immuron (ASX:IMM), which is developing oral drugs for gut di...

Ever since its 2018 initial public offering the Telix Pharmaceuticals Ltd (ASX: TLX) share price has been on a tear as investors buy into its mission to treat brain, kidney and prostate cancers via targeted molecular radiation therapy.  Be...

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

The local biotech sector is fall of landmines able to blow up your capital at any time as most biotech businesses still at the clinical trial stage have no sales revenue and huge clinical trial research costs with no guarantee of ever comm...

One area of the market which I think is home to a number of promising small cap shares is the healthcare sector. Thanks to positive tailwinds and their impressive technology or products, I believe there are many companies that are well-pla...

ASX shares at the smaller end of the market are outperforming along with the Australian dollar as the global investors up their bets that the US Federal Reserve will make its biggest ever interest rate cut in over 10 years. The S&P/ASX...

Melbourne-based Telix Pharmaceuticals (ASX:TLX) has announced the successful completion of an oversubscribed private placement to professional and sophisticated investors.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price closed 4.2% lower on the ASX yesterday as the Aussie pharmaceuticals group completed a $40 million private placement and announced a $5 million Share Purchase Plan. Why did the Telix sh...

The biotechnology sector is one of those sectors that presents an incredible opportunity for huge returns to investors. This is because the business of curing diseases can be lucrative, and any company with a small market capitalisation can...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The below-mentioned healthcare stocks have provided significant returns in the last six months and have come up with major updates today (i.e. 15th July 2019).  Let’s take a look at these updates. Rhinomed Limited (ASX: RNO) A Melbourne-ba...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is now up 157% over 2019 from 65 cents at the turn of the year to a record high of $1.67 today and there could be more to come if the oncology researcher ever manages to commercialise an...

The Elders Ltd (ASX: ELD) share price won’t be going anywhere today after the agribusiness company requested a trading halt this morning. Why are Elders’ shares in a trading halt? This morning Elders requested a trading halt whilst it unde...

Taylor Collison and Wilsons are in the market with a $40 million equity raising for Telix Pharmaceuticals on Monday morning. 

When it comes to investing in world class healthcare companies, the Australian share market offers a number of excellent options including the likes of Cochlear Limited (ASX: COH) and CSL Limited (ASX: CSL). While these blue chip shares st...

Because of positive tailwinds such as ageing populations, increased chronic disease burden, and better technologies, I believe demand for healthcare services will grow strongly over the next decade. In light of this, I think the healthcare...

With the Australian share market hitting an 11 and a half year high on Wednesday, it will not be a surprise to learn that a good number of shares are trading at 52-week highs or better. Three top shares that have just reached this mileston...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price soared 16% today to a record high of $1.16 after the oncology research business presented at a conference held by Macquarie Group Ltd (ASX: MQG). The company now has a market value of $17...

The Australian Healthcare System is amongst the most inclusive in the world, and it offers a wide range of services right from catering to general and preventative health and treating more complex conditions in patients. The healthcare syst...

Melbourne-based Telix Pharmaceuticals (ASX:TLX) has announced the extension of its research collaboration with the Institute for Radiation Sciences (IRS), Osaka University and the Department of Nuclear Medicine and Tracer Kinetics a...